Literature DB >> 9406703

Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding.

Y E Erdi1, O Mawlawi, S M Larson, M Imbriaco, H Yeung, R Finn, J L Humm.   

Abstract

BACKGROUND: It is common protocol in radionuclide therapies to administer a tracer dose of a radiopharmaceutical, determine its lesion uptake and biodistribution by gamma imaging, and then use this information to determine the most effective therapeutic dose. This treatment planning approach can be used to quantitate accurately the activity and volume of lesions and organs with positron emission tomography (PET). In this article, the authors focus on the specification of appropriate volumes of interest (VoI) using PET in association with computed tomography (CT).
METHODS: The authors have developed an automatic image segmentation schema to determine the VoI of metastases to the lung from PET images, under conditions of variable background activity. An elliptical Jaszczak phantom containing a set of spheres with volumes ranging from 0.4 to 5.5 mL was filled with F-18 activity (2-3 microCi/mL) corresponding to activities clinically observed in lung lesions. Images were acquired with a cold background and then with variable source-to-background (S/B) ratios of: 7.4, 5.5, 3.1, and 2.8. Lesion VoI analysis was performed on 10 patients with 17 primary or metastatic lung lesions, applying the optimum threshold values derived from the phantom experiments. Initial volume estimates for lung lesions were determined from CT images. Approximate S/B ratios were obtained for the corresponding lesions on F-18-fluoro-2-deoxy-D-glucose (18FDG)-PET images. From the CT estimate of the lesion size and the PET estimate of the S/B ratio, the appropriate optimum threshold could be chosen. The threshold was applied to the PET images to obtain lesion activity and a final estimate of the lesion volume.
RESULTS: Phantom data analysis showed that image segmentation converged to a fixed threshold value (from 36% to 44%) for sphere volumes larger than 4 mL, with the exact value depending on the S/B ratios. For patients, the use of optimum threshold schema demonstrated a good correlation (r = 0.999) between the initial volume from CT and the final volume derived from the 18FDG-PET scan (P < 0.02). The mean difference for those volumes was 8.4%.
CONCLUSIONS: The adaptive thresholding method applied to PET scans enables the definition of tumor VoI, which hopefully leads to accurate tumor dosimetry. This method can also be applied to small lesions (<4 mL). It should enable physicians to track objectively changes in disease status that could otherwise be obscured by the uncertainties in the region-of-interest drawing, even when the scans are delineated by the same physician.

Entities:  

Mesh:

Year:  1997        PMID: 9406703     DOI: 10.1002/(sici)1097-0142(19971215)80:12+<2505::aid-cncr24>3.3.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  138 in total

1.  Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy.

Authors:  Tony Shepherd; Mika Teras; Reinhard R Beichel; Ronald Boellaard; Michel Bruynooghe; Volker Dicken; Mark J Gooding; Peter J Julyan; John A Lee; Sébastien Lefèvre; Michael Mix; Valery Naranjo; Xiaodong Wu; Habib Zaidi; Ziming Zeng; Heikki Minn
Journal:  IEEE Trans Med Imaging       Date:  2012-06-04       Impact factor: 10.048

Review 2.  PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques.

Authors:  Habib Zaidi; Issam El Naqa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-25       Impact factor: 9.236

3.  The impact of 3D volume of interest definition on accuracy and precision of activity estimation in quantitative SPECT and planar processing methods.

Authors:  Bin He; Eric C Frey
Journal:  Phys Med Biol       Date:  2010-05-28       Impact factor: 3.609

4.  Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.

Authors:  Tomomi Nobashi; Sho Koyasu; Yuji Nakamoto; Takeshi Kubo; Takayoshi Ishimori; Young H Kim; Akihiko Yoshizawa; Kaori Togashi
Journal:  Br J Radiol       Date:  2016-01-12       Impact factor: 3.039

5.  Comparative methods for PET image segmentation in pharyngolaryngeal squamous cell carcinoma.

Authors:  Habib Zaidi; Mehrsima Abdoli; Carolina Llina Fuentes; Issam M El Naqa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05       Impact factor: 9.236

6.  From anatomical to biological target volumes: the role of PET in radiation treatment planning.

Authors:  D A X Schinagl; J H A M Kaanders; W J G Oyen
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

7.  [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy.

Authors:  Alina Berriolo-Riedinger; Claude Touzery; Jean-Marc Riedinger; Michel Toubeau; Bruno Coudert; Laurent Arnould; Christophe Boichot; Alexandre Cochet; Pierre Fumoleau; François Brunotte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06-20       Impact factor: 9.236

8.  Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.

Authors:  H A Vargas; I A Burger; D A Goldman; M Miccò; R E Sosa; W Weber; D S Chi; H Hricak; E Sala
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315

9.  A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data.

Authors:  Andrea Schaefer; Stephanie Kremp; Dirk Hellwig; Christian Rübe; Carl-Martin Kirsch; Ursula Nestle
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-26       Impact factor: 9.236

10.  Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients.

Authors:  Hansjörg Vees; Srinivasan Senthamizhchelvan; Raymond Miralbell; Damien C Weber; Osman Ratib; Habib Zaidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-26       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.